Metabolic Variation during Development in Culture of Leishmania donovani Promastigotes by Silva, Ana Marta et al.




2,3, Graham H. Coombs
1*
1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom, 2Instituto de Biologia Molecular e Celular, Universidade
do Porto, Porto, Portugal, 3Laborato ´rio de Cie ˆncias Biolo ´gicas, Faculdade de Farma ´cia da Universidade do Porto, Porto, Portugal
Abstract
The genome sequencing of several Leishmania species has provided immense amounts of data and allowed the prediction
of the metabolic pathways potentially operating. Subsequent genetic and proteomic studies have identified stage-specific
proteins and putative virulence factors but many aspects of the metabolic adaptations of Leishmania remain to be
elucidated. In this study, we have used an untargeted metabolomics approach to analyze changes in the metabolite profile
as promastigotes of L. donovani develop during in vitro cultures from logarithmic to stationary phase. The results show that
the metabolomes of promastigotes on days 3–6 of culture differ significantly from each other, consistent with there being
distinct developmental changes. Most notable were the structural changes in glycerophospholipids and increase in the
abundance of sphingolipids and glycerolipids as cells progress from logarithmic to stationary phase.
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Introduction
Leishmaniasis remains one of the major infectious diseases with
350 million people at risk in 88 countries worldwide and 2 million
estimated new cases every year [1]. The lack of effective
chemotherapy and emergence of drug resistance (reviewed in
[2]) highlights the need for an improved knowledge of the
parasite’s cell biology to discover peculiarities that could
potentially be explored as drug targets.
The Leishmania life cycle involves several developmental stages
and alternates between sand fly and mammalian hosts. A major
developmental difference is the occurrence as intracellular
amastigotes in mammalian macrophages and as extracellular
promastigotes in the sand fly. However, multiple forms of
promastigotes have been identified based on morphology,
location, infectivity, growth rate, ability to divide, and specific
features such as expression of surface molecules [3–8]. It is
believed that the parasite’s occurrence in different developmental
forms is a mechanism whereby it adapts to survive and persist in
the various environmental conditions in which it is confronted
with variations in temperature, pH, nutrient and oxygen
availability and exposure to reactive oxygen (ROS) and nitrogen
species (RNS) [9]. Despite the extensive investigations on various
features of Leishmania over many years and the recent pioneering
application of metabolomics technologies to studies on the parasite
[10–13], particularly the elucidation of ways in which amastigotes
differ from promastigotes [13–16], currently relatively little is
known about the detail of the metabolic variation that happens
during this developmental sequence in the sand fly.
The developmental sequence in the sand fly vector, which
terminates in transformation to the metacyclic form infective to a
mammalian host, appears to be mimicked, at least in part, during
growth axenically in vitro; this comprises multiplication of
procyclic promastigote forms and then differentiation to the
metacyclic form, a process known as metacyclogenesis which is
accompanied by morphological changes, including reduction in
size of the cell body and a relatively longer flagellum, and some
known biochemical changes such as lipophosphoglycan (LPG) and
surface protein expression [5–7,17–20]. Thus the in vitro system
provides an opportunity to investigate the metabolome changes
that accompany and perhaps underpin the developmental
sequence of the promastigote. In the present study, we have
applied state-of-the-art metabolomics approaches to analyse the
changes in the metabolome of promastigotes of Leishmania donovani
during culture in vitro. The results show that there is distinct
variation in the metabolome, especially in the lipid composition.
Methods
Leishmania parasites
Leishmania donovani (MHOM/NP/03/BPK206/0clone10) promas-
tigotes had been cloned from an isolate from a visceral leishmaniasis
patient sensitive to pentavalent antimonials in Nepal, as described by
Rijal and co-workers [21]. Promastigotes were grown on modified
Eagle’s medium (designated HOMEM medium, Invitrogen) supple-
mented with 20% (v/v) heat inactivated fetal calf serum (FCS, PAA
Laboratories) at 26uC. Cultures were set up initially at a density of
2.5610
5 parasites/ml and sub-passaged every 6 days.
Leishmania extracts for metabolite analysis
L. donovani promastigote cultures were initiated at 2.5610
5 cells/
ml in 16610 ml cultures in order to obtain cell samples from four
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Promastigotes from each culture were harvested at days 3, 4, 5 and
6 for metabolite extraction. The metabolite extraction was
performed as previously described [11]. Briefly, promastigotes
quenching was performed in a dry ice/ethanol bath with rapid
temperature decrease to 2uC and then immediate transfer to ice.
Two aliquots of 4610
7 cells were taken from each culture flask
(technical replicates). Cell pellets were obtained by centrifugation
at 12000 g for 10 min at 4uC, and washed 3 times in 1 ml of PBS.
For cell disruption and metabolite extraction, cell pellets were
resuspended in 200 ml cold chloroform/methanol/water (20/60/
20, v/v/v) and incubated for 1 h in a Thermomixer (1400 rpm,
4uC). After centrifugation at 12000 g for 10 min at 4uC, the
supernatant containing the extracted metabolites was recovered
and stored at 270uC until analysed.
Liquid chromatography mass spectrometry (LC-MS)
analysis and data processing
LC-MS analysis and data processing was done as described by
t’Kindt and co-workers [11,12]. Metabolite level comparisons
between the time points analyzed (after 3, 4, 5 and 6 days of in
vitro growth) were performed based on the ratio between the
intensity on each day and the mean intensity level for the 4 day
period, that is x/X3–6. The following criteria were applied to
assign differences in metabolite levels among the time points
analyzed as being potentially interesting and so worthy of inclusion
in the full analysis: (i) there was at least a 2-fold difference between
at least one of the time points when compared with the mean
intensity level; and (ii) there was a statistically significant difference
(p,0.05) between the time points being compared. The data are
expressed as intensity per 25 mg cell protein.
Statistical analysis
Statistical analysis was performed using Analysis of Variance
(ANOVA), which allowed the simultaneous comparison of all time
point analyzed: a p value smaller than 0.05 (p,0.05) was
considered significant; SPSS Statistics software (IBM) was used
to perform principal component analysis; GraphPad Prism 4 was
used for plotting the graphs and VisuMap software (VisuMap
Technologies Inc.) was used to visualise the data as heatmaps.
Results
In order to obtain detailed information about the metabolic
changes that occur during the development of promastigotes
under defined conditions in vitro, we have applied an untargeted
metabolomics approach. Promastigotes were collected after 3, 4, 5
and 6 days of in vitro growth (thus including different proportions
of various promastigote forms, including procyclic promastigotes
which dominate during logarithmic growth and the non-dividing
metacyclic forms that start to be formed at late stages of
logarithmic phase) and analyzed by LC-MS. We used four parallel
cultures (designated biological replicates) to obtain representative
data and during the cell processing from each culture two samples
were taken (designated technical replicates) to control for variation
due to technical factors. Analysis of a parasite’s metabolome needs
to take into account the changes in cell volume that occur during
development and growth. Measurement of the protein content of
the cells showed that transformation to the metacyclic form at late
logarithmic phase of growth was accompanied by a decrease in
protein content, which is thought to correlate with the decrease in
cell size (Figure 1). There was a great difference in protein content
between the cells on days 3 and 6 (p,0.0028) but also a significant
difference between the cells on days 3 and 4 (p,0.025) and days 5
and 6 (p,0.034). To assure that the metabolome analysis of the
parasite would reflect the changes observed in cell size, we have
expressed the data as intensity per cell protein (rather than per cell
number), thus facilitating meaningful comparison of the metabo-
lite levels in cells of differing volume. This method of normaliza-
tion had significant effects, for instance the general decreases in
metabolite intensity when expressed per cell number that were
observed between promastigotes on day 3 and day 6 were almost
abolished when data were expressed as intensity/mg cell protein.
Indeed the summed total of the metabolite intensities normalized
Author Summary
Leishmania infections are considered neglected tropical
diseases as the parasites affect millions of people
worldwide but there are limited research efforts aimed at
obtaining vaccines and new drugs. Leishmania has a
digenetic life cycle alternating between promastigote
forms, which develop in the sand-fly, the vector of the
disease, and an amastigote form, which grows in mammals
after being bitten by an infected sand-fly. In vitro studies
with the promastigote forms are routinely used to gain
insights about the parasite’s cell biology. Little is known
about how the different promastigotes forms are meta-
bolically adapted to their particular micro-environment in
the host or how they are pre-adapted metabolically for
infecting a mammal, thus we have undertaken a study of
the metabolite profile of L. donovani promastigotes in
order to gain an understanding of the changes that occur
during promastigote development. The analysis has
revealed that the changes in promastigotes’ metabolome
between days 3 and 6 take place in a progressive manner;
however major differences were observed when compar-
ing the promastigotes on days 3 and 6. An increase in lipid
abundance as promastigote development occurred was
notable and is likely to reflect remodelling of the parasite’s
surface in readiness for infecting a mammal.
Figure 1. Relantionship between protein content and cell
density during in vitro growth of L. donovani promastigotes. L.
donovani promastigotes were seeded at 2.5610
5 parasites/ml, counted
daily and harvested at days 3, 4, 5 and 6. Protein content was
determined by the Lowry method. Each value is a mean 6 standard
deviation from four cultures. Statistically significant differences
observed between the days evaluated: days 3 and 4, p,0.05; days 5
and 6, p,0.05; days 4 and 6, p,0.05; days 3 and 6, p,0.01.
doi:10.1371/journal.pntd.0001451.g001
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when expressed as intensity/cell number it declined 33% on day 6.
We believe that this method of taking into account the changes in
cell size during growth is currently optimal and provides a means
of generating data that are meaningful and can be interpreted with
confidence.
In order to understand better the metabolic fluctuations as the
promastigotes developed over the four days, we compared the
profiles of metabolites levels (Figures 2A and 3). The analysis
shown in Figure 2A (in which the metabolite intensity level on
each day is compared with the mean level over the 4 day period)
highlights that, of the total metabolites identified, the levels of the
majority remained rather similar throughout although 26.9%
differed by at least 2-fold on one of the days when compared with
the mean. The day 3 levels were the most different from the others
(22% being at least 2-fold different from the centered-mean for the
period analyzed) and with just some metabolites differing greatly at
other times. This is consistent with there being a progressive
change in many metabolite levels over the four day period.
However, comparison between the metabolite intensities on days 3
and 6 revealed that 48.4% of all the metabolites identified differed
by more than 2-fold (Figure 2B), suggesting a significant difference
in metabolic profile between promastigote populations in loga-
rithmic (mainly procyclic promastigotes) and stationary phases
(containing many metacyclic promastigotes).
The metabolic profile was also analysed by principal component
analysis (PCA). PCA is an unsupervised clustering technique that
allows the reduction of the data into two dimensions (principal
component 1 [PC1] and principal component 2 [PC2]), which
capture and enable visualization of data variability; this method is
generally applied to large sets of data, such as those resulting from
microarray or metabolomic analyses, as a way of obtaining a
summary or overview of all samples, to find clusters and trends,
and to identify the outliers. It is recommended as a starting point
for analysis of multivariate data [22]. The PCA score plots
(Figure 4) of the LC-MS data show clearly the identification of four
distinct clusters, each one corresponding to one of the groups of
samples analyzed on a particular day of growth. PC1 and PC2
account for more than 81% of the variables which shows the clear
metabolic differences between the samples. Moreover, the tight
clustering within each group indicates good reproducibility. The
data in Figure 4 show that promastigotes on days 4 and 5 are
aligned closely with each other indicating that they have a similar
metabolic profile that is clearly distinguished from those on days 3
and 6 (which explains 59.0% of total variance given by the second
principal component). These data are consistent with there being
metabolic changes as the promastigotes develop from procyclic
promastigotes to metacyclic promastigotes, and the relatively large
number of metabolites that differ in levels significantly between
days 3 and 6.
The identity of the metabolites was carried out based on the
databases detailed by t’Kindt and co-workers [11,12]. We were
able to identify 368 putative metabolites (267 at ,1 parts per
million [ppm] deviation and 101 at the 1–2 ppm deviation level).
The compounds identified belong to a wide range of metabolic
pathways and include amino acids, nucleosides, carbohydrates,
fatty acyls, sterols and glycerophospholipids among others, as
shown in Figure 3. The full list of putatively identified
metabolites at days 3, 4, 5 and 6 at below 1 ppm and between
1–2 ppm deviation are provided in Tables S1 and S2 of
supplementary data, respectively. The majority of the metabo-
lites remained at a relatively constant level. Indeed, the overall
sum of intensities of the identified metabolites in the samples
from the different days show that there is little apparent variation
in the total metabolome identified, with the only difference being
between day 3 and day 4 (Figure S1); clearly, however, such data
have to be used with caution as not all of the parasite’s
metabolites are included in the dataset and the method is not
fully quantitative. There were, however, some apparent varia-
tions within each group of metabolites (Figure S2). Lipids, in
general, increased substantially from day 3 to day 6. Carbohy-
drates and nucleosides similarly apparently increase in abun-
dance, whereas other groups of metabolites including amino
acids and derivatives, organic acids and alcohols remain at
relatively constant levels.
All metabolites that differed from the mean for the 4-day period
by at least a 2-fold on one or more days and were statistically
different between the time points analyzed (p,0.05) are repre-
sented in heatmap format to visualize the main changes that occur
during transformation of promastigotes in logarithmic phase to
those in stationary phase (Figure 5) and the intensity levels are
provided on Table S3. This group (97 in total, 26% of the total
number of metabolites putatively identified) includes metabolites
representative of all of the compound categories shown in Figure 3
with the exception of organic acids and alcohols. It was possible to
distinguish five general patterns by which metabolites fluctuated
during the 4-day period analyzed (Figure S3 and Table S3). The
levels of some metabolites continually increased from day 3 to day
6 (pattern 1, 74% of the 97 varying metabolites), while the
opposite happened with others (pattern 3, 9%). Other metabolites
showed peak levels on days 4 or 5 which then declined (pattern 2,
9%), while others decreased from day 3 to day 4 and then
increased (pattern 4, 2%). Some metabolites had a fluctuating
profile showing an increase followed by a decrease and then
another increase (pattern 5, 6%).
A more detailed analysis of each of the categories of metabolites
suggests specific variation potentially related with the cell stage.
For instance, analysis of structural properties of the fatty acyl side
chains of phosphatidylethanolamine (PE) and phosphatidylcholine
(PC) lipids revealed that there was an increased abundance of the
PC lipids with lower unsaturated fatty acyl chains as the
promastigotes developed from day 3 to day 6 (Figure 6 and S4
in supplementary data); this seems also to happen in PE lipids, but
less so than with PC lipids. These data suggest that there are
changes in the composition of membranes with development from
procyclic to metacyclic promastigotes. Another class of metabolites
showing striking differences depending on the cell stage were the
sphingolipids (SLs). In Leishmania, SLs are not essential for growth
but they are for differentiation, probably due to the high demand
in vesicular trafficking required for parasite remodeling [23]. The
abundance of these metabolites in general increased on day 5 and
greatly on day 6, such that for some of the SLs identified, such as
N-(eicosanoyl)-sphinganine, N-(hexadecanoyl)-sphinganine and
heptadecasphinganine, the day 6 intensity amounted to more
than 70% of the total amount detected over the four days
(Figure 7A). A similar situation was seen with some of the
identified glycerolipids, with the diacylglycerol putatively identified
as DAG(42:3) being especially increased on day 6 (Figure 7B). The
abundance of sterols, prenol lipids and fatty acyl metabolites
generally increased during growth and thus were more abundant
on days 5 and 6, although there were exceptions such as N-(11Z-
eicosaenoyl)-ethanolamine and N-(11Z,14Z-eicosaenoyl)-ethanol-
amine (Figures S5 and S6).
In contrast to the lipids, amino acids and derivatives in general
did not differ greatly during the four day period, although some
were less abundant on day 6 (proline, glutamate-semialdehyde,
homocysteine, carnitine and cystathionine among others) while
others were increased (for example N-butyrylglycine, lysine,
Metabolome of Leishmania Promastigotes
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intracellular metabolites in L. donovani promastigotes detected from day 3 to day 6. Metabolite intensity levels on each day were compared with the
mean level over the 4-day period. Following a logarithmic transformation (base 2), the relative level of each metabolite was plotted. Dotted lines
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Figure S7). A higher abundance of carbohydrates, such as
maltohexose among others, was observed as cells reach stationary
phase (Table S3 and Figure S8). The intensity variation for
hypoxanthine and xanthine over the 4 days had a clearly distinct
pattern from the other nucleosides or nucleoside conjugates, with a
large increase in the abundance of these metabolites on day 6,
while, for example, cytosine and deoxycytidine decreased in
abundance on day 6 (Table S3 and Figure S9). The great increase
in the abundance of hypoxanthine and xanthine at day 6 is
responsible for the large change observed in the overall abundance
of all metabolites included in this group (Figure S2); the overall
abundance of this group was relatively unchanged over the 4 day
period of analysis if these two metabolites were not included. None
of the metabolites included in the organic acids group accomplish
the criteria defined, despite, for example, the statistically
significant difference observed in the levels of mevalonate on day
6 (Figure S10). A marked decrease in abundance on day 6 was also
observed for 5-methyl-THF, dihydrobiopterin and N-acetylpu-
trescine (Table S3 and Figure S11).
Figure 3. Intracellular metabolic fluctuations during in vitro development of L. donovani promastigotes. Profiles of all intracellular
metabolites identified below 2 ppm deviation in relative levels. Metabolite levels on each day were compared with the mean level over the 4-day
period. Following a logarithmic transformation (base 2), the relative level of each metabolite is shown; log2 (x/X3–6) below 21 or above 1 indicates a
2-fold change; x, time point analyzed (day 3, 4, 5 or 6). Metabolite profiles are ordered by compound category shown on the left and log values of
measurements are color-coded as indicated in the scale on the right of the heat map, from green to red.
doi:10.1371/journal.pntd.0001451.g003
represent the fold-change cut-off considered as significantly different between the day analyzed and the mean level of the 4-day period: log2 (dx/
X3–6) below or above 1 indicates a 2-fold change; dx, time point analyzed (day 3, 4, 5 or 6). The metabolites differing at least by 2-fold on one of the
days when compared with the mean were 26.9% of the all of the metabolites identified. (B) Comparison between day 6 (d6) and day 3 (d3) intensity
ratios for each identified metabolite. All metabolites within the 2 ppm cut-off are included and following a logarithmic transformation (base 2) the
average signal intensity ratios of d6/d3 for all metabolites were plotted. Dotted lines represent the fold-change cut-off in this study for a given
metabolite profile being considered to be significantly different between day 6 and day 3: log2 (metabolite intensity ratio) below 21 or above 1
indicates a 2-fold change between time points compared. The metabolites differing at least by 2-fold between day 6 and day 3 were 48.4% of the
total number of metabolites identified.
doi:10.1371/journal.pntd.0001451.g002
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Leishmania promastigotes development in the sand fly includes a
wide range of modifications in order to prepare the parasite for
transmission to a mammalian host. The number of distinct
developmental stages that occur is uncertain for although many
have been named and identified based on morphology [3,4] most
have not been sufficiently characterized to be certain that they are
truly distinct developmental stages. As expected, in vitro we were
able to observe various morphological forms of L. donovani
promastigotes but the major clear difference was the appearance
of small morphs as the culture reached stationary phase, when
metacyclic forms are predominant. This reflects the remodeling of
cell shape during life cycle transitions and involved a decrease in
protein content (Figure 1). This was taken into consideration in
analyzing the metabolite dataset and indeed the data were
normalized to protein content as a means of taking into account
changes in cell size.
Analysis of metabolome during in vitro growth of promastigotes
revealed that whereas the overall metabolite abundance remained
relatively constant there were variations in the levels of individual
metabolites, suggesting that parasite differentiation from procyclic
to metacyclic forms takes place in a progressive manner and
involves changes in certain individual or groups of metabolites.
This study reinforces the idea that there are multiple forms of
promastigotes that are adapted differently at the metabolic level,
presumably reflecting the differing challenges that they face
naturally in the sand fly. It has been postulated previously from
studies on morphology of Leishmania promastigotes in sand flies
and in vitro cultures that the parasite undergoes similar
developmental transitions in vitro as occur in the sand fly host
[24], despite the absence of the host pressure. This has been
interpreted as the parasite being genetically pre-adapted to survive
in the sand fly. The biochemical changes that accompany these
morphological/developmental changes are not fully known,
although some characteristics of the metacyclic promastigote of
L. major have been reported. Differentiation to the infective
metacyclic promastigote form involves modifications in LPG
structure [6,25], which have been shown to occur both in in vitro
culture and during in vivo development in the sand fly [26].
HASPB and SHERP are stage-specific proteins present in the
infective stages, with SHERP being exclusively present in the
metacyclic forms; the stage-specific expression of both has been
observed in vitro as well as during the development in the vector
[8]. Other surface molecules, including the metallopeptidase
GP63, also undergo changes in expression pattern as the
promastigotes development progresses [27]. The LPG modifica-
tions are essential for parasite infectivity and occur in vitro and in
vivo demonstrating that in the absence of the host this essential
processes still occurs; these findings are suggestive that other
changes similarly also occur in vitro and the data of our current
study show that indeed this is the case.
Metacyclogenesis is marked by a great increase in membrane
trafficking and remodeling [28] and previous studies have shown
that the organization of Leishmania membrane differs between
procyclic and metacyclic promastigotes, in part due to the
distribution of LPG into lipid rafts during differentiation [29].
Phospholipids (PLs) account for ,70% of total cellular lipids in
Leishmania, with PC, the most abundant glycerophospholipid,
predominantly present in a diacyl form [30] with unusually long
and unsaturated fatty acid species [31]. These properties, the acyl
length and degree of unsaturation, may play an important role in
the fluidity of Leishmania membrane, thus they are likely to be
regulated throughout parasite development in its hosts. Indeed,
our data show that promastigote phospholipid composition
changed remarkably in terms of the unsaturation levels observed
in the fatty acid chains, in particular of PC lipids. Promastigotes in
stationary phase (day 6) presented a higher abundance of PC lipids
with lower levels of unsaturation than those observed on day 3
(Figure 6), revealing a shift towards lower unsaturation of PC lipids
and consequently a decrease in membrane fluidity with metacyclic
promastigote generation. These observed changes in membrane
Figure 4. L. donovani promastigote development is accompanied by significant changes in the metabolome. Principal component
analysis of all metabolites identified by LC-MS in cell extracts from L. donovani promastigotes harvested on days 3, 4, 5 and 6 of in vitro growth; each
datapoint corresponds to the analysis of one biological replicate. Principal component 1 and principal component 2 explain 59.0% and 22.3% of the
total variance, respectively.
doi:10.1371/journal.pntd.0001451.g004
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adapted for survival upon infecting a mammalian host, at which
time it is confronted by a dramatic increase in temperature. Thus
perhaps the change in membrane composition enables the parasite
to maintain an appropriate membrane fluidity even at the higher
temperature encountered. It is well known that the well-being of
organisms is dependent upon the maintenance of optimal level of
membrane fluidity [32]. In yeast, changes in the degree of
unsaturation of fatty acids has been reported as a response to
changes in the environmental temperature and complements other
mechanisms such as modifications in fatty acid chain length,
branching and cellular fatty acid content [33]. A recent study by
Turk and co-workers [34] have related membrane fluidity to the
adaptation level of different yeast to environmental stresses and to
their growth temperature range, demonstrating that plasma-
membrane fluidity can be used as an indicator of fitness for
survival in extreme environments [34]. Changes in membrane
fluidity in plants was also suggested to be crucial in sensing and
influencing gene expression during temperatures fluctuations [35].
Alterations in membrane fluidity have been associated with the
occurrence of drug resistance in Leishmania; it is thought that
membrane lipid composition may influence drug-membrane
interactions and interfere with drug uptake by the amastigotes
residing in the mammalian host [36–38]. Indeed, comparison of
promastigotes derived from clinical L. donovani isolates with
different antimonial sensitivity has shown a shift towards higher
unsaturation of PC lipids in drug-resistant clones, suggesting an
increase in membrane fluidity that may be related to the changes
in uptake ability observed in the drug-resistant cell lines [12].
Another group of lipids that notably increased in abundance
during L. donovani promastigotes development in vitro were the SLs
(Figure 7A). SLs are not required for growth of Leishmania, since
parasites that completely lack SLs grew normally in logarithmic
phase and were still able to make ‘‘lipid rafts’’. However, deletion
of spt2-, the gene that encodes the key de novo biosynthetic
enzyme serine palmitoyltransferase subunit 2, resulted in parasites
deficient in de novo SLs synthesis that once in the stationary phase
were not able to differentiate into metacyclic forms [23]. The
increase in SLs during stationary phase we have found in this study
is consistent with the requirement of these metabolites for
differentiation to metacyclic froms. SLs are considered essential
membrane components in all eukaryotes, mediating many
signaling pathways including those key for apoptosis, growth and
differentiation [39]. However, in Leishmania the primary role of SLs
appears to be the provision of ethanolamine, as ethanolamine
supplementation was able to overcome the phenotype observed in
the SL-deficient mutant parasites [40]. Ethanolamine and choline
are essential nutrients, and when available exogenously they can
be salvaged by Leishmania via membrane transporters [41,42].
Thus the significance of SL biosynthesis is likely to be stage-
specific, being important in those stages in the sand fly that cannot
rely upon salvaged ethanolamine. Indeed, amastigotes deficient in
de novo SLs synthesis recovered from a mammalian host showed
normal levels of inositolphosphoryl ceramide (IPC) and thus
amastigotes seems to be able to perform SLs salvage [43].
Glycerolipids, represented by diacylglycerols (DAG) and
triacylglycerols (TAG), also increased in abundance as L. donovani
promastigote development progressed (Figure 7B). PC and PE
lipids are synthesized by conjugation of a lipid anchor such as
DAG with either CDP-choline or CDP-ethanolamine, the last step
of the in de novo biosynthesis of phospholipids (the Kennedy
pathway) (reviewed in [44]). Thus the observed increase in neutral
lipids correlates well with the changes observed in Leishmania
membrane lipid composition during promastigote development.
Sterol and prenol lipids also increased with time in culture,
although the changes during L. donovani promastigotes develop-
ment were not so accentuated as for SLs and glycerolipids. Sterols
are the target of the important antileishmanial drug amphotericin
B [36] and they may also play a significant role in the activity of
miltefosine against the parasite, as sterol depletion led to a
decrease in susceptibility [45]. Effectiveness of these drugs is
mainly dependent on their interaction with the Leishmania
membrane, thus it is clear that the ability of the parasite to
change its lipid membrane composition, which occurs inherent
during its life cycle, should be taken into consideration when
considering new drug formulations.
Leishmania parasites are auxotrophic for many amino acids and
must scavenge essential amino acids from their hosts. Besides the
use in protein biosynthesis, some amino acids, notably proline, can
be used as major energy sources [46]. Recently, Saunders and co-
workers have reported that aspartate, alanine and glutamate are
internalized by L. mexicana promastigotes and incorporated into the
TCA cycle, revealing the importance of this pathway in glutamate,
glutamine and proline synthesis and demonstrating that the TCA
cycle in Leishmania is not only a catabolic pathway [47]. One
notable feature in the levels of amino acids and amino acid
conjugates during growth of promastigotes in vitro was a large
increase in metabolites of fatty acids named acyl glycines
(valerylglycine, tiglyglycine, N-butyrylglycine). Increases in levels
of acyl glycines in higher eukaryotes is associated with mitochon-
drial energy metabolism disorders, indeed the measurement of
these metabolites is used as a diagnostic tool. Glycine conjugation
is considered to be an important detoxification system, preventing
the accumulation of acyl-CoA esters in several inherited metabolic
disorders of humans [48]. Moreover, valerylglycine was found to
be increased in urine of Plasmodium vivax-infected individuals,
which indicates an alteration in the fatty acid metabolism during
infection [49]. These changes in acylglycines abundance during
promastigote development could reflect changes in mitochondrial
metabolism, but caution needs to be exercised as increased levels
of this group of compounds was also found in drug-resistant
parasites [12] and also in genetically manipulated mutants (A.M.
Silva et al., unpublished results) – which indicates that the levels of
these metabolites may be disturbed in a variety of situations.
Leishmania also take up from their environment other essential
nutrients, such as purines and growth factors. Biopterin and folate
uptake has been shown to decrease when promastigote have
entered stationary phase [50], which is consistent with our findings
that there was a decrease in abundance of 5-methyl-THF and
dihydrobiopterin in L. donovani promastigotes at day 6 of in vitro
growth. Indeed, low levels of tetrahydrobiopterin were associated
Figure 5. Heatmap depicting significant fluctuations in L. donovani promastigotes intracellular metabolome during in vitro
development. Profiles over 4 days of intracellular metabolites that differed at least by 2-fold from the mean levels in at least one of the time points
analyzed. Metabolite intensity levels on each day were compared with the mean level over the 4 day period. Following a logarithmic transformation
(base 2), the relative level of each metabolite is shown; log2 (x/X3–6) below 21 or above 1 indicates a 2-fold change; x, time point analyzed (day 3, 4, 5
or 6). Metabolites labelled with * represent peaks with multiple potential identifications, for which just one is shown in this figure but the full listi s
given in the Supporting Information; metabolite profiles are ordered by compound category shown on the left and log values of ratios are color-
coded as indicated in the scale on the right of the heat map, from green to red.
doi:10.1371/journal.pntd.0001451.g005
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metacyclic form and thus postulated to be an important factor
controlling this process [51]. Leishmania parasites are not able to
synthesize purines de novo and need to acquire either nucleosides
or nucleobases [52]. Hypoxanthine uptake by L. major promas-
tigotes is greatly reduced in stationary phase compared with
logarithmic growth phase. This was shown to correlate with
down-regulation of expression of the NT3 permease as
promastigotes reach stationary phase [53] and it was reasoned
that these changes reflected the fact that at this stage the
population is mainly composed by non-dividing cells, the
metacyclic promastigotes, that do not require purines for mitosis.
Our findings of an increase in the levels of hypoxanthine and
xanthine at day 6 of L. donovani promastigotes in vitro growth
Figure 6. Comparative analysis of phosphatidylcholines and phosphatidylethanolamines in L. donovani promastigotes on days 3
and 6. Fatty acyl structure properties in (A) phosphatidylcholines (PC) and (B) phosphatidylethanolamines (PE) for each phospholipid detected on
day 6 and day 3. The x-axis shows the total number of unsaturated bonds present in the 2 fatty acyl chains, while the y-axis shows the length of the
fatty acyl chains in total number of carbon units. Data are shown as ratios of signal intensity, day 6/day 3, after a logarithmic transformation (base 2)
and represented by a color code as indicated in the scale on the right of the heat map, from green to red, where green represents a decrease and a
red an increase in abundance of the given phospholipid on day 6.
doi:10.1371/journal.pntd.0001451.g006
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vitro. (A) Sphingolipids and sphingoid base and (B) glycerolipid metabolites abundance is represented for each day as a percentage of the total
abundance detected, which comprises the sum of the total metabolite intensity on each of the 4 days analysed. Metabolites labelled with * represent
peaks with multiple potential identifications, for which just one is shown in this figure but the full list is given in the Supporting Information. DAG,
diacylglycerol; TAG, triacylglycerol.
doi:10.1371/journal.pntd.0001451.g007
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can speculate that these higher levels in the metacyclic forms are
beneficial in enabling the subsequent differentiation events after
infection of a mammal, a transition phase that occurs in the
parasitophorous vacuole of a macrophage where availability of
some nutrients may be limiting [54,55].
Overall the results of this study have provided convincing data
that promastigotes of Leishmania at different stages of culture in
vitro differ from each other significantly in terms of the
composition of their metabolome, whereas the total metabolite
abundance appears to remain relatively constant as the promas-
tigotes develop from day 3 to day 6. The study has provided
insights into the overall changes that occur, which adds to the
many previous reports on changes in individual metabolites,
groups of metabolites and enzymatic reactions involved in
metabolite production (see, for example, [16,46,56–58]). Our
data are consistent in particular with previous findings obtained
using other approaches, such as changes observed in the content of
sphingolipids and other lipids that may contribute to successful
parasite survival in the mammalian host [23,57]. These changes
observed undoubtedly reflect adaptations to differing conditions
that Leishmania encounters in its two hosts, but the full
understanding of how these adaptations function require addi-
tional data on the environments themselves (the detailed content of
the parasitophorous vacuole in a macrophage and the intestinal
tract of the sand fly, and how these change with time, are largely
unknown) as well as more complete analyses of metabolism of
individual promastigote forms and if possible integration of the
generated data with those arising from other –omics approaches.
However, understanding the variation in metabolism of promas-
tigotes will be informative in elucidating more fully the metabolic
capabilities of Leishmania and hopefully highlight unusual features
that can be exploited in novel approaches to designing therapies.
Supporting Information
Figure S1 Overall metabolite levels remain similar
during L. donovani promastigotes development in vitro.
Sum of total metabolite intensities from L. donovani promastigotes
identified by LC-MS analysis at days 3, 4, 5 or 6 of in vitro growth.
(PDF)
Figure S2 Overall metabolite levels for each compound
category during L. donovani promastigotes development
in vitro. Sum of total metabolite intensities from L. donovani
promastigotes identified by LC-MS analysis at days 3, 4, 5 or 6 of
in vitro growth grouped by compound categories.
(PDF)
Figure S3 Patterns of metabolite variation in level
during L. donovani promastigote in vitro growth from
day 3 to day 6. Analysis of L. donovani promastigotes metabolome
at day 3, 4, 5 and 6 allowed the distinction of 5 patterns (1–5)
based on the metabolic profile for each metabolite that differed in
intensity by 2-fold or more from the mean levels in at least one of
the time points analyzed (a total of 97 metabolites). The relative
level of each metabolite is shown, following logarithmic transfor-
mation (base 2); log2 (x/X3–6) below 21 or above 1 indicates a 2-
fold change; x, time point analyzed (day 3, 4, 5 or 6). (A) Pattern 1
(74% of all metabolites considered) and (C) pattern 3 (9%) include
metabolites that increased or decreased, respectively, continuously
during all the whole period analyzed; (B) pattern 2 (9%) include
metabolites which had peak levels on days 4 or 5 but which then
declined; (D) pattern 4 (2%) metabolite levels decreased from day 3
to day 4 and then increased and (E) pattern 5 (6%) include
metabolites that showed an increase followed by a decrease and
then another increase.
(PDF)
Figure S4 Glycerophospholipids abundance during L.
donovani promastigotes development in vitro. Glycer-
ophospholipids abundance is represented for each metabolite on
each day as a percentage of the total abundance detected, which
comprises the sum of the total metabolite intensity during the 4-
day period of analysis.
(PDF)
Figure S5 Sterol and prenol lipids abundance during L.
donovani promastigotes development in vitro. Sterol and
prenol lipids abundance is represented for each metabolite on each
day as a percentage of the total abundance detected, which
comprises the sum of the total metabolite intensity during the 4-
day period of analysis. Metabolites labelled with * represent peaks
with multiple potential identifications, for which just one is shown
in this figure but the full list is given in Tables S1 and S2.
(PDF)
Figure S6 Fatty acyls abundance during L. donovani
promastigotes development in vitro. Fatty acyls abundance
is represented for each metabolite on each day as a percentage of
the total abundance detected, which comprises the sum of the total
metabolite intensity during the 4-day period of analysis. Metab-
olites labelled with * represent peaks with multiple potential
identifications, for which just one is shown in this figure but the full
list is given in Tables S1 and S2.
(PDF)
Figure S7 Amino acids and amino acids conjugates
abundance during L. donovani promastigotes develop-
ment in vitro. Amino acids and amino acids conjugates
abundance is represented for each metabolite on each day as a
percentage of the total abundance detected, which comprises the
sum of the total metabolite intensity during the 4-day period of
analysis. Metabolites labelled with * represent peaks with multiple
potential identifications, for which just one is shown in this figure
but the full list is given in Tables S1 and S2.
(PDF)
Figure S8 Carbohydrates and carbohydrate conjugates
abundance during L. donovani promastigotes develop-
ment in vitro. Carbohydrates and carbohydrate conjugates
abundance is represented for each metabolite on each day as a
percentage of the total abundance detected, which comprises the
sum of the total metabolite intensity during the 4-day period of
analysis. Metabolites labelled with * represent peaks with multiple
potential identifications, for which just one is shown in this figure
but the full list is given in Tables S1 and S2.
(PDF)
Figure S9 Nucleosides and nucleoside conjugates abun-
dance during L. donovani promastigotes development in
vitro. Nucleosides and nucleoside conjugate metabolites abun-
dance is represented for each metabolite on each day as a
percentage of the total abundance detected, which comprises the
sum of the total metabolite intensity during the 4-day period of
analysis. Metabolites labelled with * represent peaks with multiple
potential identifications, for which just one is shown in this figure
but the full list is given in Tables S1 and S2.
(PDF)
Figure S10 Organic acids abundance during L. dono-
vani promastigotes development in vitro. Organic acids
abundance is represented for each metabolite on each day as a
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www.plosntds.org 11 December 2011 | Volume 5 | Issue 12 | e1451percentage of the total abundance detected, which comprises the
sum of the total metabolite intensity during the 4-day period of
analysis. Metabolites labelled with * represent peaks with multiple
potential identifications, for which just one is shown in this figure
but the full list is given in Tables S1 and S2.
(PDF)
Figure S11 Vitamins and cofactors, ketones and alde-
hydes, heterocyclic molecules, amines and alcohols
abundance during L. donovani promastigotes develop-
ment in vitro. Vitamins and cofactors, ketones and aldehydes,
heterocyclic molecules, amines and alcohols abundance is
represented for each metabolite on each day as a percentage of
the total abundance detected, which comprises the sum of the total
metabolite intensity during the 4-day period of analysis. Metab-
olites labelled with * represent peaks with multiple potential
identifications, for which just one is shown in this figure but the full
list is given in Tables S1 and S2.
(PDF)
Table S1 Metabolites identified below 1 ppm deviation
in samples of L. donovani promastigotes from day 3 to
day 6 of in vitro growth. For each compound the following
information is shown: ionisation (ESI) mode; detected mass;
retention time (min); putative metabolite identification; ppm
deviation between detected mass and theoretical mass of the
putative metabolite identified; intensity per 25 mg cell protein for
each sample; average intensity per 25 mg cell protein in each time-
point analyzed (3D, 4D, 5D or 6D); standard deviation in each
time point analyzed; log base 2 of ratio of the average signal
intensity in each time point against the mean intensity level during
the 4 day period; F test statistics and p values obtained by analysis
of variance (ANOVA), indicating whether or not there was a
statistically significant difference between the time points analyzed;
decision on whether or not the compound was significantly
changed in level based on a two-fold or higher average difference
in signal intensity in at least one of the time points analyzed and
statistical significance (p,0.05); compound category.
(XLS)
Table S2 Metabolites identified between 1–2 ppm devi-
ation in samples of L. donovani promastigotes from day
3t od a y6o fin vitro growth. The data presented are as
described for Table S1.
(XLS)
Table S3 Intensity levels of metabolites that differ
significantly during L. donovani promastigote develop-
ment in vitro. Metabolites are ordered by compound category;
for each metabolite is shown the average intensity per 25 mg cell
protein at days 3, 4, 5 and 6 and the respective metabolic profile
pattern (analysis shown in Figure S2). Metabolites labelled with *
represent peaks with multiple potential identifications, for which
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